Kazutaka Otsuji1, Takeshi Sasaki2, Masahiko Tanabe1, Yasuyuki Seto1,3. 1. Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 2. Department of Next-Generation Pathology Information and Networking, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. takesasa@m.u-tokyo.ac.jp. 3. Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Abstract
BACKGROUND: Breast fibroadenoma (FA) and phyllodes tumour (PT) often have variations of gene mediator complex subunit 12 (MED12) and mutations in the telomerase reverse transcriptase promoter region (TERTp). TERTp mutation is usually tested by Sanger sequencing. In this study, we compared Sanger sequencing and droplet-digital PCR (ddPCR) to measure TERTp mutations in FA and PT samples. METHODS: FA and PT samples were collected from 82 patients who underwent surgery at our institution from 2005 to 2016. MED12 mutations for all cases and TERTp mutations for 17 tumours were detected by Sanger sequencing. ddPCR was performed to analyse TERTp mutation in all cases. RESULTS: A total of 75 samples were eligible for analysis. Sanger sequencing detected MED12 mutations in 19/44 FA (42%) and 21/31 PT (68%). Among 17 Sanger sequencing-tested samples, 2/17 (12%) were TERTp mutation-positive. In ddPCR analyses, a significantly greater percentage of PT (19/31, 61%) was TERTp mutation-positive than was FA (13/44, 30%; P = 0.0046). The mutation positivity of TERTp and MED12 did not correlate, in either FA or PT. CONCLUSIONS: ddPCR was more sensitive for detecting TERTp mutation than Sanger sequencing, being able to elucidate tumorigenesis in FA and PT.
BACKGROUND:Breast fibroadenoma (FA) and phyllodes tumour (PT) often have variations of gene mediator complex subunit 12 (MED12) and mutations in the telomerase reverse transcriptase promoter region (TERTp). TERTp mutation is usually tested by Sanger sequencing. In this study, we compared Sanger sequencing and droplet-digital PCR (ddPCR) to measure TERTp mutations in FA and PT samples. METHODS: FA and PT samples were collected from 82 patients who underwent surgery at our institution from 2005 to 2016. MED12 mutations for all cases and TERTp mutations for 17 tumours were detected by Sanger sequencing. ddPCR was performed to analyse TERTp mutation in all cases. RESULTS: A total of 75 samples were eligible for analysis. Sanger sequencing detected MED12 mutations in 19/44 FA (42%) and 21/31 PT (68%). Among 17 Sanger sequencing-tested samples, 2/17 (12%) were TERTp mutation-positive. In ddPCR analyses, a significantly greater percentage of PT (19/31, 61%) was TERTp mutation-positive than was FA (13/44, 30%; P = 0.0046). The mutation positivity of TERTp and MED12 did not correlate, in either FA or PT. CONCLUSIONS: ddPCR was more sensitive for detecting TERTp mutation than Sanger sequencing, being able to elucidate tumorigenesis in FA and PT.
Authors: Weng Khong Lim; Choon Kiat Ong; Jing Tan; Aye Aye Thike; Cedric Chuan Young Ng; Vikneswari Rajasegaran; Swe Swe Myint; Sanjanaa Nagarajan; Nur Diyana Md Nasir; John R McPherson; Ioana Cutcutache; Gregory Poore; Su Ting Tay; Wei Siong Ooi; Veronique Kiak Mien Tan; Mikael Hartman; Kong Wee Ong; Benita K T Tan; Steven G Rozen; Puay Hoon Tan; Patrick Tan; Bin Tean Teh Journal: Nat Genet Date: 2014-07-20 Impact factor: 38.330
Authors: Anna Sapino; Martino Bosco; Paola Cassoni; Isabella Castellano; Riccardo Arisio; Gábor Cserni; Angelo P Dei Tos; Nicoletta Fortunati; Maria G Catalano; Gianni Bussolati Journal: Mod Pathol Date: 2006-04 Impact factor: 7.842
Authors: Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell Journal: Nucleic Acids Res Date: 2014-10-29 Impact factor: 16.971
Authors: Fresia Pareja; Felipe C Geyer; Rahul Kumar; Pier Selenica; Salvatore Piscuoglio; Charlotte K Y Ng; Kathleen A Burke; Marcia Edelweiss; Melissa P Murray; Edi Brogi; Britta Weigelt; Jorge S Reis-Filho Journal: NPJ Breast Cancer Date: 2017-10-12